Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1297766

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1297766

Global Cosmetic Surgery Market - 2023-2030

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

The Global Cosmetic Surgery Market reached US$ 61.3 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 132.2 billion by 2030. The global cosmetic surgery market is expected to exhibit a CAGR of 10.4% during the forecast period (2023-2030). Cosmetic plastic surgery is performed to alter look. For some, it implies reshaping the body's contour and form, smoothing wrinkles, or removing bald spots. Others choose for varicose vein therapy or breast augmentation.

Cosmetic surgery primary principal is focused to enhance the appearance. Cosmetic surgery treatments, techniques, and philosophies are solely focused on improving look. The primary aims are to improve visual appeal, symmetry, and proportion. Aesthetic surgery can be done on any part of the head, neck, or body. Cosmetic operations are considered elective since they address regions that function normally.

Market Dynamics

Rise in Female Cosmetic Surgery Patients

According to the International Society of Aesthetic Plastic Surgery (ISAPS), the increase in female cosmetic surgery patients can be ascribed to females' increased attention on physical appearance and rising per capita spending in emerging economies. This factor is bolstered further by the expanding number of medical spas that provide a variety of services and boast cutting-edge technology and items. These factors contribute to the market's female segment's growth.

Rise In the Demand for Minimally Invasive Surgical Procedures

One of the primary benefits of cosmetic surgery is that the effects are generally long-lasting or permanent because of the increased demand for cosmetic operations, it has been more freely available, and numerous clinics have been established.

These important advantages for cosmetic surgery led to market expansion. Expanding disposable income, more societal awareness, expanding demand for these treatments in the entertainment business, and a rise in the frequency of catastrophic accidents needing reconstructive alterations are all driving drivers for the market.

High Cost of Cosmetic Surgeries

Cosmetic surgery has become 'not so simply accessible' in many emerging and middle-income nations. This appears to be the primary issue impeding market expansion. Recovery period can often be as lengthy as 2-3 weeks, preventing the market from increasing.

Also, plastic surgery in India costs between INR 15,000 ($188) and INR 2,50,000 ($3,133), or even more, depending on the technique chosen, difficulties encountered during the operation, additional services provided by the hospital, consultations, and tests. This prohibitive price of therapy may stifle market expansion.

COVID-19 Impact Analysis

Many cosmetic surgery clinics and organizations had to temporarily stop or reduce their services during the early phases of the epidemic owing to lockdown precautions and limits on elective procedures. As a result, the number of cosmetic treatments performed has decreased significantly. Fear of getting the virus, financial uncertainty, and a focus on basic healthcare services all contributed to a drop in demand for aesthetic operations.

Many people postponed or cancelled elective operations in order to priorities their health and safety throughout the epidemic. The amount of aesthetic plastic surgery treatments, for instance, fell by 10.9% in 2020, with 77.8% of clinicians worldwide experiencing temporary practise closures owing to the COVID-19 epidemic. Nonsurgical procedures (mostly fillers and hair removal treatments) grew, albeit at a slower rate than in previous years. As a result of this, overall operations decreased by 1.8%.

Segment Analysis

The global cosmetic surgery market is segmented based on procedure and product and region.

The Breast augmentation Surgical Procedure Segment Will Account for Approximately 36.7% During the Forecast Period

Breast augmentation remains the most common surgical procedure for women, while surgery to remove implants increased by 22.6 percent, and breast lifts increased by 31.4% in the last year, according to the ISAPS survey. For instance, The International Society of Aesthetic Plastic Surgery (ISAPS) presented the findings of its annual Global Survey on Aesthetic/Cosmetic treatments, which revealed a 19.3% rise in cosmetic surgery treatments.

Geographical Analysis

North America is the Dominating Region During the Forecast Period

North America has the largest share accounting for 40.7% during the forecast period. The size of the market in the area is predicted to grow steadily in the future years. The increased acceptance of cosmetic surgery and widespread knowledge are important driving elements behind the market's expansion. Furthermore, fast improvements in associated technologies like as improved silicone and polymer implants are propelling the region's cosmetic surgery business.

Competitive Landscape

The major global players include: AbbVie, Bausch Health Companies, Candela Syneron, Cynosure Technologies, Galderma SA, Johnson and Johnson, Merz Pharma GmbH, Sientra, Sinclair Pharma, and Teoxane Laboratories.

Why Purchase the Report?

  • To visualize the global cosmetic surgery market segmentation based on the procedures and product and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global cosmetic surgery market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global cosmetic surgery market report would provide approximately 92 tables, 108 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: MD215

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1 Snippet by Procedures
  • 3.2 Snippet by Product
  • 3.4 Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1 Rise in Female Cosmetic Surgery Patients
      • 4.1.1.2 Rise in the demand for minimally invasive surgical procedures
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Cosmetic Surgeries
    • 4.1.3. Opportunity
      • 4.1.3.1The introduction of self-monitoring apps
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Procedure

  • 7.1. Abdominoplasty
  • 7.2. Blepharoplasty
  • 7.3. Mammoplasty
  • 7.4. Buttock augmentation
  • 7.5. Laser Skin Rejuvenation
  • 7.6. Face Surgery
  • 7.7. Liposuction
  • 7.8. Other

8. By Product

  • 8.1. Implants
    • 8.1.1. Lip Implants
    • 8.1.2. Breast Implants
    • 8.1.3. Buttock Implants
    • 8.1.4. Chin and Cheek Implants
  • 8.2. Equipment
    • 8.2.1. Hair removal lasers
    • 8.2.2. Dermal resurfacing lasers
    • 8.2.3. Liposuction equipment
    • 8.2.4. Microdermabrators
  • 8.3. Injectables
    • 8.3.1. Botulinum toxin
    • 8.3.2. Collagen
    • 8.3.3. Hyaluronic acid

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. The U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. The UK
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. AbbVie
    • 11.1.1. Company overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Bausch Health Companies
  • 11.3. Candela Syneron
  • 11.4. Cynosure Technologies
  • 11.5. Galderma SA
  • 11.6. Johnson and Johnson
  • 11.7. Merz Pharma GmbH
  • 11.8. Sientra
  • 11.9. Sinclair Pharma
  • 11.10. Teoxane Laboratories

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!